SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-065480
Filing Date
2019-03-06
Accepted
2019-03-06 15:34:02
Documents
2
Group Members
CADENA LLCEDWIN M. KANIA, JR.FLAGSHIP PIONEERING, INC.FLAGSHIP VENTURELABS IV, LLCFLAGSHIP VENTURELABS V MANAGER LLCFLAGSHIP VENTURELABS V, LLCFLAGSHIP VENTURES 2007 GENERAL PARTNER LLCFLAGSHIP VENTURES FUND 2007, L.P.FLAGSHIP VENTURES FUND IV GENERAL PAR

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d713613dsc13d.htm SC 13D 277941
2 EXHIBIT 1 d713613dex991.htm EX-99.1 21659
  Complete submission text file 0001193125-19-065480.txt   301880
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Subject) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90946 | Film No.: 19662362
SIC: 2836 Biological Products, (No Diagnostic Substances)